MPM Capital
Signal active
Investment Firm
Overview
MPM Capital is a healthcare investment firm that invests in companies developing therapeutic technologies in oncology. The company invests in life sciences companies that seek to cure diseases by translating science into clinical outcomes. The company prefers to invest in the biotechnology, healthcare, and life sciences sectors.
Highlights
Founded
1996
Industry
Venture Capital
Employees
11-50
Investment
299
Lead Investment
96
Exits
99
Stages
Late Stage Venture, Early Stage Venture, Private Equity, Seed
Investor Type
Private Equity Firm, Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
MPM Capital, established in 1996 and headquartered in United States, North America., specializes in Late Stage Venture, Early Stage Venture, Private Equity, Seed investments across Biotechnology, Health Care, Pharmaceutical, Food and Beverage, Manufacturing, Electronics, Medical, Wellness, Medical Device, Financial Services. The organization boasts a portfolio of 299 investments, with an average round size of $47.2M and 99 successful exits. Their recent investments include TaiGen Biotechnology, Taiwan Sugar Corporation, YFY Inc., Innovative Spinal Technologies, OrbiMed. The highest investment round they participated in was $1120.5B. Among their most notable exits are TaiGen Biotechnology and Taiwan Sugar Corporation. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
MPM Capital has made 299 investments. Their most recent investment was on May 02, 2024, when Reunion Neuroscience raised $103.0M.
MPM Capital has made 54 diversity investments. Their most recent diversity investment was on Feb 15, 2024, when Firefly Bio raised $94.0M.
investments
299
Diversity investments
54
Lead investments
96
Number of exits
99
Investments
299
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Feb 15, 2024 | Firefly Bio | Biotechnology | 94.0M |
| Feb 22, 2024 | Frontier Medicines | Biotechnology | 80.0M |
| May 02, 2024 | Reunion Neuroscience | Biotechnology | 103.0M |
| Jun 20, 2024 | - | - | 40.0M |
Exits
99
Funding Timeline
Funding rounds
299
Investors
0
Funds
14
Funding Rounds
299
MPM Capital has raised 299 rounds. Their latest funding was raised on Jun 20, 2024 from a Series A - āshibio round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Feb 15, 2024 | Series A - Firefly Bio | - | 94.0M | - |
| Feb 22, 2024 | Series C - Frontier Medicines | - | 80.0M | - |
| May 02, 2024 | Series A - Reunion Neuroscience | - | 103.0M | - |
| Jun 20, 2024 | Series A - āshibio | - | 40.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.